Tsubota Laboratory Incorporated

Tokyo Stock Exchange 4890.T

Tsubota Laboratory Incorporated Capital Expenditure for the year ending March 31, 2024: USD -79.29 K

Tsubota Laboratory Incorporated Capital Expenditure is USD -79.29 K for the year ending March 31, 2024, a 78.39% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).
  • Tsubota Laboratory Incorporated Capital Expenditure for the year ending March 31, 2023 was USD -366.99 K, a 38.15% change year over year.
  • Tsubota Laboratory Incorporated Capital Expenditure for the year ending March 31, 2022 was USD -593.35 K, a -44.89% change year over year.
  • Tsubota Laboratory Incorporated Capital Expenditure for the year ending March 31, 2021 was USD -409.51 K, a -916.34% change year over year.
  • Tsubota Laboratory Incorporated Capital Expenditure for the year ending March 31, 2020 was USD -40.29 K.
Key data
Date Capital Expenditure Free Cash Flow Depreciation And Amortization Deferred Income Tax
Market news
Tokyo Stock Exchange: 4890.T

Tsubota Laboratory Incorporated

CEO Mr. Kazuo Tsubota M.B.A., M.D., Ph.D.
IPO Date June 23, 2022
Location Japan
Headquarters 304 Toshin Shinanomachi-ekimae Building
Employees 7
Sector Health Care
Industries
Pharmaceuticals Cosmetics
Description

Tsubota Laboratory Incorporated engages in the research and development of pharmaceuticals and medical devices for the treatment of myopia, dry eyes, and presbyopia. The company was incorporated in 2012 and is based in Tokyo, Japan.

StockViz Staff

January 15, 2025

Any question? Send us an email